Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Alterations of oligodendrocyte and myelin energy metabolism in multiple sclerosis
Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system
(CNS), characterized by demyelination and neurodegeneration. Oligodendrocytes play a …
(CNS), characterized by demyelination and neurodegeneration. Oligodendrocytes play a …
Drugs targeting CD20 in multiple sclerosis: pharmacology, efficacy, safety, and tolerability
Currently, there are four monoclonal antibodies (mAbs) that target the cluster of
differentiation (CD) 20 receptor available to treat multiple sclerosis (MS): rituximab …
differentiation (CD) 20 receptor available to treat multiple sclerosis (MS): rituximab …
Dietary polyphenols, microbiome, and multiple sclerosis: From molecular anti-inflammatory and neuroprotective mechanisms to clinical evidence
G La Rosa, MS Lonardo, N Cacciapuoti… - International journal of …, 2023 - mdpi.com
Multiple sclerosis (MS) is a multifactorial, immune-mediated disease caused by complex
gene-environment interactions. Dietary factors modulating the inflammatory status through …
gene-environment interactions. Dietary factors modulating the inflammatory status through …
Whole-Body Cryostimulation in Multiple Sclerosis: A Sco** Review
Multiple sclerosis (MS) is the most common cause of non-traumatic long-term disability in
young adults. Whole-body cryostimulation (WBC) is a cold-based physical therapy known to …
young adults. Whole-body cryostimulation (WBC) is a cold-based physical therapy known to …
Highly effective therapy versus escalation approaches in early multiple sclerosis: what is the future of multiple sclerosis treatment?
Multiple sclerosis (MS) is a chronic disease of the central nervous system with a global
prevalence of more than 2 million cases worldwide 1 and nearly one million cases in the US …
prevalence of more than 2 million cases worldwide 1 and nearly one million cases in the US …
Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study
Background and objectives: Alemtuzumab demonstrated superior efficacy versus
subcutaneous interferon (IFN) beta-1a in participants with relapsing-remitting multiple …
subcutaneous interferon (IFN) beta-1a in participants with relapsing-remitting multiple …
Leveraging real-world evidence and observational studies in treating multiple sclerosis
In a rapidly evolving treatment landscape for multiple sclerosis (MS), the utilization of real-
world observational studies has become increasingly valuable for decisionmaking at the …
world observational studies has become increasingly valuable for decisionmaking at the …
[HTML][HTML] Potential Application of Plant-Derived Compounds in Multiple Sclerosis Management
Multiple sclerosis (MS) is a chronic autoimmune disorder characterized by inflammation,
demyelination, and neurodegeneration, resulting in significant disability and reduced quality …
demyelination, and neurodegeneration, resulting in significant disability and reduced quality …
Shifting from the treat-to-target to the early highly effective treatment approach in patients with multiple sclerosis–real-world evidence from Germany
S Papukchieva, AS Stratil, M Kahn… - Therapeutic …, 2024 - journals.sagepub.com
Background: While evidence highlights the effectiveness of initiating disease-modifying
therapy with a high-efficacy medication for multiple sclerosis (MS) patients with poor …
therapy with a high-efficacy medication for multiple sclerosis (MS) patients with poor …
Advanced MRI techniques: Diagnosis and follow-up of multiple sclerosis
Brain and spinal cord imaging plays a pivotal role in aiding clinicians with the diagnosis and
monitoring of multiple sclerosis. Nevertheless, the significance of magnetic resonance …
monitoring of multiple sclerosis. Nevertheless, the significance of magnetic resonance …